VJHemOnc is committed to improving our service to you

SOHO Italy 2020 | Changing treatment landscape of AML

VJHemOnc is committed to improving our service to you

Claudio Cerchione

Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, updates us on novel therapies in acute myeloid leukemia (AML) and the evolving treatment landscape. Dr Cerchione discusses the use of CPX-351 in patients with secondary AML as well as the use of combination therapies to improve the outcomes of patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter